Table 7 Description of papers relating to aspects of biobanking
Reference | Subject of paper |
|---|---|
[357] | Introduces concept of adding value to stakeholders (patient donors/funders/research customers) and to find balance between aspects of sustainability (acceptability/efficiency/accomplishment) |
[358] | Feasibility of simplified consent form for biobanking. Result indicates simplified forms combined with supplemental information for further reading effective in minimising form length and complexity |
[359] | Review paper detailing best practice guidelines for sample collection and storage, management of data and infrastructure. In addition, ethical, legal and social issues are explored |
[360] | Paper discussing aspects of embryonic stem cell banking that can be applied to iPSCS |
[361] | Key issues relating to delivery and safety testing of iPSC stocks for use in research and therapy. Importance of international and national coordinated banking systems are also discussed |
[362] | Description of enclosed culture system for iPSCS and neural precursors for use in preclinical and basic research |